Skip to main content
Journal cover image

Re: Re: Singh et al.: Nepafenac 0.3% after cataract surgery in patients with diabetic retinopathy: results of 2 randomized phase 3 studies (Ophthalmology. 2017;124:776-785) REPLY

Publication ,  Journal Article
Singh, RP; Lehmann, R; Martel, J; Jong, K; Pollack, A; Tsorbatzoglou, A; Staurenghi, G; Cervantes-Coste Cervantes, G; Alpern, L; Modi, S ...
Published in: OPHTHALMOLOGY
January 1, 2018

Duke Scholars

Published In

OPHTHALMOLOGY

EISSN

1549-4713

ISSN

0161-6420

Publication Date

January 1, 2018

Volume

125

Issue

1

Start / End Page

E11 / E12

Publisher

ELSEVIER SCIENCE INC

Related Subject Headings

  • Ophthalmology & Optometry
  • 3212 Ophthalmology and optometry
  • 1117 Public Health and Health Services
  • 1113 Opthalmology and Optometry
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Singh, R. P., Lehmann, R., Martel, J., Jong, K., Pollack, A., Tsorbatzoglou, A., … Jaffe, G. J. (2018). Re: Re: Singh et al.: Nepafenac 0.3% after cataract surgery in patients with diabetic retinopathy: results of 2 randomized phase 3 studies (Ophthalmology. 2017;124:776-785) REPLY. OPHTHALMOLOGY, 125(1), E11–E12.
Singh, Rishi P., Robert Lehmann, Joseph Martel, Kevin Jong, Ayala Pollack, Alexis Tsorbatzoglou, Giovanni Staurenghi, et al. “Re: Re: Singh et al.: Nepafenac 0.3% after cataract surgery in patients with diabetic retinopathy: results of 2 randomized phase 3 studies (Ophthalmology. 2017;124:776-785) REPLY.” OPHTHALMOLOGY 125, no. 1 (January 1, 2018): E11–12.
Singh RP, Lehmann R, Martel J, Jong K, Pollack A, Tsorbatzoglou A, Staurenghi G, Cervantes-Coste Cervantes G, Alpern L, Modi S, Svoboda L, Adewale A, Jaffe GJ. Re: Re: Singh et al.: Nepafenac 0.3% after cataract surgery in patients with diabetic retinopathy: results of 2 randomized phase 3 studies (Ophthalmology. 2017;124:776-785) REPLY. OPHTHALMOLOGY. ELSEVIER SCIENCE INC; 2018 Jan 1;125(1):E11–E12.
Journal cover image

Published In

OPHTHALMOLOGY

EISSN

1549-4713

ISSN

0161-6420

Publication Date

January 1, 2018

Volume

125

Issue

1

Start / End Page

E11 / E12

Publisher

ELSEVIER SCIENCE INC

Related Subject Headings

  • Ophthalmology & Optometry
  • 3212 Ophthalmology and optometry
  • 1117 Public Health and Health Services
  • 1113 Opthalmology and Optometry
  • 1103 Clinical Sciences